Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Advocacy at a Glance 3/19/21 Advocacy at a Glance 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More 3/19/21 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More Advocacy at a Glance 3/13/21 Advocacy at a Glance 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Advocacy at a Glance 3/6/21 Advocacy at a Glance 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More 11/21/19 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More Advocacy at a Glance 11/15/19 Advocacy at a Glance 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More Advocacy at a Glance 2/5/16 Advocacy at a Glance 2/5/16 Obama-Proposed “Cancer Moonshot” Includes Monies for FDA Read More Advocacy at a Glance 1/29/16 Advocacy at a Glance 1/29/16 Senator Murray Wants FDA at “Full Throttle;” Pushes Mandatory FDA Funding and more Read More Advocacy at a Glance 1/15/16 Advocacy at a Glance 1/15/16 FY 17 Appropriations Process to Be Speeded Up and more Read More Advocacy at a Glance 12/11/15 Advocacy at a Glance 12/11/15 Senate HELP Committee Vote on FDA Commissioner Nomination Possible in January and more Read More Advocacy at a Glance 9/18/15 Advocacy at a Glance 9/18/15 Federal Spending Negotiations Continue as Fiscal Deadline Inches Closer and more Read More
Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Advocacy at a Glance 3/19/21 Advocacy at a Glance 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
Advocacy at a Glance 3/13/21 Advocacy at a Glance 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
Advocacy at a Glance 3/6/21 Advocacy at a Glance 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More
Advocacy at a Glance 11/15/19 Advocacy at a Glance 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More
Advocacy at a Glance 2/5/16 Advocacy at a Glance 2/5/16 Obama-Proposed “Cancer Moonshot” Includes Monies for FDA Read More
Advocacy at a Glance 1/29/16 Advocacy at a Glance 1/29/16 Senator Murray Wants FDA at “Full Throttle;” Pushes Mandatory FDA Funding and more Read More
Advocacy at a Glance 1/15/16 Advocacy at a Glance 1/15/16 FY 17 Appropriations Process to Be Speeded Up and more Read More
Advocacy at a Glance 12/11/15 Advocacy at a Glance 12/11/15 Senate HELP Committee Vote on FDA Commissioner Nomination Possible in January and more Read More
Advocacy at a Glance 9/18/15 Advocacy at a Glance 9/18/15 Federal Spending Negotiations Continue as Fiscal Deadline Inches Closer and more Read More
